Szu‐Yu Pan

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Lineage Tracing Reveals Distinctive Fates for Mesothelial Cells and Submesothelial Fibroblasts during Peritoneal Injury

Yi‐Ting Chen, Yu-Ting Chang, Szu‐Yu Pan et al. · Journal of the American Society of Nephrology · 2014 · 149 citations · Full text

Pathology, Cytoskeleton, Mesothelial Cells +23

A Zinc Finger-Containing Glycine-Rich RNA-Binding Protein, atRZ-1a, Has a Negative Impact on Seed Germination and Seedling Growth of Arabidopsis thaliana Under Salt or Drought Stress Conditions

Y.-O. Kim, Szu‐Yu Pan, Christian Jung et al. · Plant and Cell Physiology · 2007 · 105 citations · Full text

Botany, Genetics, Molecular Biology +18

DNA methyltransferase inhibition restores erythropoietin production in fibrotic murine kidneys

Yu-Ting Chang, Ching-Chin Yang, Szu‐Yu Pan et al. · Journal of Clinical Investigation · 2016 · 86 citations · Full text

Iron Metabolism, Immunology, Renal Inflammation +25